Tag: Solid tumors

Studies show that scalp cooling can help over 50% of patients retain most of their hair during certain chemotherapy treatments. This article explores what are the indications for coldcap therapy, who is eligible, and how it works.

In recent clinical trials, the targeted drug trastuzumab deruxtecan (Enhertu) demonstrated a 72% improvement in progression-free survival for certain patients with HER2-positive metastatic breast cancer compared to a different therapy. This innovative medication, which incorporates the chemotherapy payload **Deruxtecan**, represents a significant advancement in oncology by selectively delivering potent treatment directly to cancer cells.